Effect of the ratios of estradiol increase on the outcome of in vitro fertilization-embryo transfer with antagonist regimens: a single center retrospective cohort study
- PMID: 36864417
- PMCID: PMC9979484
- DOI: 10.1186/s12884-023-05438-3
Effect of the ratios of estradiol increase on the outcome of in vitro fertilization-embryo transfer with antagonist regimens: a single center retrospective cohort study
Abstract
Background: The outcome of in vitro fertilization-embryo transfer (IVF) is often determined according to follicle and estradiol levels following gonadotropin stimulation. In previous studies, although most of them analyzed the estrogen level from ovaries or the average estrogen level of a single follicle, there was no study on the ratio of estrogen increase, which was also correlated with pregnancy outcomes in the clinic. This study aimed to make timely adjustments to follow-up medication to improve clinical outcomes based on the potential value of estradiol growth rate.
Methods: We comprehensively analyzed estrogen growth during the entire ovarian stimulation period. Serum estradiol levels were measured on the day of gonadotropin treatment (Gn1), five days later (Gn5), eight days later (Gn8), and on the trigger day (HCG). This ratio was used to determine the increase in estradiol levels. According to the ratio of estradiol increase, the patients were divided into four groups: A1 (Gn5/Gn1 ≤ 6.44), A2 (6.44 < Gn5/Gn1 ≤ 10.62), A3 (10.62 < Gn5/Gn1 ≤ 21.33), and A4 (Gn5/Gn1 > 21.33); B1 (Gn8/Gn5 ≤ 2.39), B2 (2.39 < Gn8/Gn5 ≤ 3.03), B3 (3.03 < Gn8/Gn5 ≤ 3.84), and B4 (Gn8/Gn5 > 3.84). We analyzed and compared the relationship between data in each group and pregnancy outcomes.
Results: In the statistical analysis, the estradiol levels of Gn5 (P = 0.029, P = 0.042), Gn8 (P < 0.001, P = 0.001), and HCG (P < 0.001, P = 0.002), as well as Gn5/Gn1 (P = 0.004, P = 0.006), Gn8/Gn5 (P = 0.001, P = 0.002), and HCG/Gn1 (P < 0.001, P < 0.001) both had clinical guiding significance, and lower one significantly reduced the pregnancy rate. The outcomes were positively linked to groups A (P = 0.036, P = 0.043) and B (P = 0.014, P = 0.013), respectively. The logistical regression analysis revealed that group A1 (OR = 0.376 [0.182-0.779]; P = 0.008*, OR = 0.401 [0.188-0.857]; P = 0.018*) and B1 (OR = 0.363 [0.179-0.735]; P = 0.005*, OR = 0.389 [0.187-0.808]; P = 0.011*) had opposite influence on outcomes.
Conclusion: Maintaining a serum estradiol increase ratio of at least 6.44 on Gn5/Gn1 and 2.39 on Gn8/Gn5 may result in a higher pregnancy rate, especially in young people.
Keywords: Antagonist regimen; Cumulative live birth rates; Estradiol level; IVF; Increase ratio.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
[Value of serum estradiol concentration in predicting the clinical outcome of IVF-ET in patients receiving long protocol of GnRHa].Nan Fang Yi Ke Da Xue Xue Bao. 2011 Feb;31(2):365-8. Nan Fang Yi Ke Da Xue Xue Bao. 2011. PMID: 21354932 Chinese.
-
A decrease in serum estradiol levels after human chorionic gonadotrophin administration predicts significantly lower clinical pregnancy and live birth rates in in vitro fertilization cycles.Hum Reprod. 2012 Sep;27(9):2690-7. doi: 10.1093/humrep/des216. Epub 2012 Jun 29. Hum Reprod. 2012. PMID: 22752608 Free PMC article.
-
New Perspectives on Criteria for the Determination of HCG Trigger Timing in GnRH Antagonist Cycles.Medicine (Baltimore). 2016 May;95(20):e3691. doi: 10.1097/MD.0000000000003691. Medicine (Baltimore). 2016. PMID: 27196479 Free PMC article.
-
The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.Clin Endocrinol (Oxf). 2018 Jan;88(1):77-87. doi: 10.1111/cen.13481. Epub 2017 Oct 16. Clin Endocrinol (Oxf). 2018. PMID: 28960429
-
Can Ratios Between Prognostic Factors Predict the Clinical Pregnancy Rate in an IVF/ICSI Program with a GnRH Agonist-FSH/hMG Protocol? An Assessment of 2421 Embryo Transfers, and a Review of the Literature.Reprod Sci. 2021 Feb;28(2):495-509. doi: 10.1007/s43032-020-00307-2. Epub 2020 Sep 4. Reprod Sci. 2021. PMID: 32886340 Review.
Cited by
-
Real-world practices of hormone monitoring during ovarian stimulation in assisted reproductive technology: a global online survey.Front Endocrinol (Lausanne). 2023 Nov 28;14:1260783. doi: 10.3389/fendo.2023.1260783. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38089631 Free PMC article.
-
Effect of hCG day's estradiol levels on pregnancy outcomes following GnRH antagonist protocol: a retrospective study of 3192 fresh embryo transfer cycles.BMC Pregnancy Childbirth. 2025 Aug 12;25(1):836. doi: 10.1186/s12884-025-07929-x. BMC Pregnancy Childbirth. 2025. PMID: 40797168 Free PMC article.
-
Basal serum luteinizing hormone, total testosterone, and free testosterone levels do not impact IVF outcomes in patients with polycystic ovary syndrome.J Turk Ger Gynecol Assoc. 2024 Dec 10;25(4):192-199. doi: 10.4274/jtgga.galenos.2024.2024-2-9. J Turk Ger Gynecol Assoc. 2024. PMID: 39658861 Free PMC article.
-
Serum and follicular fluid metabolome and markers of ovarian stimulation.Hum Reprod. 2023 Nov 2;38(11):2196-2207. doi: 10.1093/humrep/dead189. Hum Reprod. 2023. PMID: 37740688 Free PMC article.
-
Estrogens and breast cancer.Ann Oncol. 2025 Feb;36(2):134-148. doi: 10.1016/j.annonc.2024.10.824. Epub 2024 Nov 8. Ann Oncol. 2025. PMID: 39522613 Free PMC article. Review.
References
-
- Ozdegirmenci O, Dilbaz S, Cinar O, Aydin S, Beydilli G, Cakir L, Guven ES, Akyol M, Haberal A. Can serum oestradiol be a predictor of quality of oocytes and embryos, maturation of oocytes and pregnancy rate in ICSI cycles? Gynecol Endocrinol. 2011;27(4):279–285. doi: 10.3109/09513590.2010.491168. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources